Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Carotenoid terpene pigment found in various pla...
Triazole; 14-α demethylase inhibitor, potentia...
1-Naphthalenacetic acid derivative, NSAID; COX-...
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
ALK and IGF-1R inhibitor.
Endogenous NMDA receptor antagonist.
Anthracycline, DNA intercalator; topoisomerase ...
Selective inhibitor of LRRK2.
CDK2 inhibitor
Mycotoxin derivative; actin polymerization inhi...
Dual RAF/EGFR inhibitor.
Inhibitor of Monoacyglycerol lipase (MAGL).
Terpene found in the rind of various citrus fru...
Synthetic steroid; glucocorticoid agonist.
Steroidogenesis inhibitor
Fluoroquinolone; bacterial DNA gyrase inhibitor...
PRMT5 inhibitor
B-Raf and c-Raf inhibitor.
Carbonic anhydrase inhibitor.